Your browser doesn't support javascript.
loading
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study.
Shaygannejad, V; Fayyazi, E; Badihian, S; Mirmosayyeb, O; Manouchehri, N; Ashtari, F; Asgari, N.
Afiliação
  • Shaygannejad V; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Fayyazi E; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Badihian S; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mirmosayyeb O; Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Manouchehri N; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ashtari F; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Asgari N; Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
J Neurol ; 266(3): 642-650, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30635724
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Avaliação de Resultados em Cuidados de Saúde / Rituximab / Fatores Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Avaliação de Resultados em Cuidados de Saúde / Rituximab / Fatores Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article